CSF1R and neoplasm: Blockade of M-CSF signaling using anti-CSF1R antibodies severely diminished the number of proliferating KCs in tumor-adjacent areas, leading to impaired expansion of resident KCs upon E. coli–sgMafb/Maf treatment (Figure 5, I and J).